Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Bernd  Muehlenweg

Bernd Muehlenweg

CBO, Nanobiotix

Bernd holds a doctorate in chemistry from the Technical University of Munich, extended by management training at the St. Gallen Business School, as well as several merger/acquisition and negotiation techniques seminars. He was responsible for several negotiations and the execution of several licences and marketing contracts. Mr Muehlenweg is co-author of more than 17 publications and 2 patents.

He is a member of the Pharma Licensing Club of Germany (Pharmalizenzclub) and the Pharma Licensing Club France. More recently, Bernd was Business Development Director for Wilex AG in Munich, where he made significant contributions to position Wilex as a leader in the market of development of therapeutic molecules and diagnostic tools in oncology. He joined Nanobiotix in 2011 where he is responsible for ensuring the sustainable growth of the Company by concluding strategic alliances with partners.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd